Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$417K Hold
17,312
0.03% 117
2026
Q1
$486K Sell
17,312
-374
-2% -$9.96K 0.04% 105
2025
Q4
$440K Sell
17,686
-225
-1% -$5.67K 0.04% 111
2025
Q3
$456K Buy
17,911
+68
+0.4% +$1.68K 0.04% 106
2025
Q2
$433K Sell
17,843
-2,209
-11% -$51.5K 0.04% 110
2025
Q1
$508K Sell
20,052
-426
-2% -$11.1K 0.05% 100
2024
Q4
$543K Sell
20,478
-264
-1% -$7.16K 0.05% 98
2024
Q3
$600K Sell
20,742
-1,591
-7% -$46.4K 0.06% 94
2024
Q2
$625K Sell
22,333
-2,500
-10% -$68.8K 0.06% 87
2024
Q1
$689K Sell
24,833
-250
-1% -$6.94K 0.07% 88
2023
Q4
$722K Hold
25,083
0.08% 85
2023
Q3
$832K Buy
25,083
+2,494
+11% +$88.2K 0.11% 81
2023
Q2
$828K Hold
22,589
0.1% 82
2023
Q1
$922K Hold
22,589
0.13% 60
2022
Q4
$1.16M Buy
22,589
+700
+3% +$33.6K 0.17% 49
2022
Q3
$958K Sell
21,889
-550
-2% -$26.7K 0.15% 54
2022
Q2
$1.18M Sell
22,439
-328
-1% -$16.7K 0.17% 53
2022
Q1
$1.18M Sell
22,767
-40
-0.2% -$2.08K 0.15% 56
2021
Q4
$1.35M Buy
22,807
+1,500
+7% +$74.3K 0.15% 53
2021
Q3
$916K Sell
21,307
-733
-3% -$32.5K 0.12% 58
2021
Q2
$863K Buy
22,040
+107
+0.5% +$4.16K 0.11% 61
2021
Q1
$795K Sell
21,933
-1,200
-5% -$42.6K 0.11% 60
2020
Q4
$852K Sell
23,133
-325
-1% -$11.9K 0.13% 53
2020
Q3
$816K Buy
23,458
+120
+0.5% +$4.21K 0.13% 51
2020
Q2
$724K Hold
23,338
0.13% 49
2020
Q1
$722K Sell
23,338
-386,906
-94% -$13.2M 0.16% 45
2019
Q4
$15.3M Buy
410,244
+31,432
+8% +$1.12M 2.5% 12
2019
Q3
$12.9M Buy
378,812
+2,959
+0.8% +$108K 2.48% 11
2019
Q2
$15.4M Buy
375,853
+37,064
+11% +$1.47M 2.98% 7
2019
Q1
$13.7M Buy
338,789
+3,620
+1% +$145K 2.92% 4
2018
Q4
$13.9M Sell
335,169
-5,360
-2% -$223K 3.28% 6
2018
Q3
$14.2M Buy
340,529
+228
+0.1% +$8.78K 3.03% 6
2018
Q2
$11.7M Buy
340,301
+1,164
+0.3% +$39.8K 2.62% 8
2018
Q1
$11.4M Buy
339,137
+4,728
+1% +$163K 2.66% 10
2017
Q4
$11.5M Buy
334,409
+5,732
+2% +$195K 2.65% 7
2017
Q3
$11.1M Sell
328,677
-4,158
-1% -$134K 2.78% 10
2017
Q2
$10.6M Sell
332,835
-2,326
-0.7% -$73.4K 2.7% 12
2017
Q1
$10.9M Sell
335,161
-2,065
-0.6% -$65.1K 2.84% 8
2016
Q4
$10.4M Buy
337,226
+1,173
+0.3% +$35.8K 2.86% 10
2016
Q3
$10.8M Sell
336,053
-3,743
-1% -$125K 2.95% 8
2016
Q2
$11.4M Buy
339,796
+6,151
+2% +$196K 3.14% 4
2016
Q1
$9.38M Buy
333,645
+2,474
+0.7% +$70.7K 2.68% 12
2015
Q4
$10.1M Sell
331,171
-1,228
-0.4% -$38.6K 2.71% 9
2015
Q3
$9.9M Buy
332,399
+1,430
+0.4% +$45.9K 2.82% 9
2015
Q2
$10.5M Sell
330,969
-5,736
-2% -$187K 2.83% 10
2015
Q1
$11.1M Sell
336,705
-6,921
-2% -$220K 2.95% 6
2014
Q4
$11.1M Buy
343,626
+316
+0.1% +$9.06K 2.92% 8
2014
Q3
$9.63M Sell
343,310
-1,903
-0.6% -$53.4K 2.43% 12
2014
Q2
$9.72M Buy
345,213
+640
+0.2% +$18.2K 2.42% 13
2014
Q1
$10.5M Buy
344,573
+51,955
+18% +$1.55M 2.73% 11
2013
Q4
$8.5M Buy
292,618
+3,585
+1% +$104K 2.15% 16
2013
Q3
$7.88M Buy
289,033
+4,181
+1% +$114K 2.23% 14
2013
Q2
$7.57M Buy
+284,852
New +$7.87M 2.26% 14

Other funds holding PFE

J.M. Forbes & Co's PFE Position: Q2 2026 in Review

J.M. Forbes & Co held its Pfizer (PFE) position steady in Q2 2026 at 17,312 shares worth $417K. The position accounts for 0.03% of the portfolio, ranked #117.

J.M. Forbes & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.4M in Q2 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • J.M. Forbes & Co held 17,312 shares of Pfizer worth $417K as of Q2 2026.
  • J.M. Forbes & Co left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.03% of J.M. Forbes & Co's portfolio in Q2 2026, its #117 holding.
  • J.M. Forbes & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • J.M. Forbes & Co's Pfizer position peaked at $15.4M in Q2 2019.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on J.M. Forbes & Co's 13F filing for Q2 2026, filed 20 Jul 2026.